Shameze Rampertab sold ASXC
February 4, 2024 · Form 4 insider transaction
Shameze Rampertab sold 58,333 shares of Asensus Surgical, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.; Lapse of forfeiture restrictions on the first one-third of one-half of a PRSU award granted on February 3, 2023. One-half of the PRSUs were forfeited upon failure to achieve one of two performance goals. The remaining earned PRSUs will vest on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan ad the Reporting Person's Employment Agreement.